Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned
Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned Herantis Pharma PlcCompany release 2 December 2019 at 8:00 pm THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc's ("Herantis" or the "Company") Offering (as defined below) has ended and the board of directors of the Company has